AQST - Aquestive spikes as FDA rejects ARS Pharma's epinephrine spray
2023-09-20 12:35:22 ET
More on Aquestive
- Seeking Alpha’s Quant Rating on Aquestive Therapeutics
- Historical earnings data for Aquestive Therapeutics
- Financial information for Aquestive Therapeutics
- Aquestive Therapeutics, Inc. (AQST) Q2 2023 Earnings Call Transcript
- Aquestive Therapeutics: Developing A Better Solution To A $1 Billion/Year Anaphylaxis Problem
For further details see:
Aquestive spikes as FDA rejects ARS Pharma’s epinephrine spray